CONMED Corporation (CNMD)
Financial leverage ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 2,322,490 | 2,328,460 | 2,297,680 | 2,306,250 | 2,315,740 | 2,285,620 | 2,309,260 | 2,300,020 | 2,325,680 | 2,322,720 | 2,320,120 | 2,297,590 | 2,292,040 | 2,072,260 | 1,785,720 | 1,766,020 | 1,754,090 | 1,761,970 | 1,746,610 | 1,751,670 |
| Total stockholders’ equity | US$ in thousands | 1,008,260 | 1,002,870 | 977,636 | 962,681 | 932,896 | 881,832 | 854,664 | 834,222 | 796,205 | 780,194 | 752,453 | 745,545 | 716,337 | 672,968 | 789,546 | 785,435 | 755,683 | 744,499 | 725,570 | 709,038 |
| Financial leverage ratio | 2.30 | 2.32 | 2.35 | 2.40 | 2.48 | 2.59 | 2.70 | 2.76 | 2.92 | 2.98 | 3.08 | 3.08 | 3.20 | 3.08 | 2.26 | 2.25 | 2.32 | 2.37 | 2.41 | 2.47 |
September 30, 2025 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,322,490K ÷ $1,008,260K
= 2.30
Peer comparison
Sep 30, 2025
Company name
Symbol
Financial leverage ratio
CONMED Corporation
CNMD
2.30
Abbott Laboratories
ABT
1.65
Stryker Corporation
SYK
2.13